A novel blood-borne virus called the human hepegivirus 1 (HHpgV-1) was recently
discovered in hemophilia patients. The present study aimed to investigate the presence of …

The purpose of this essay is to recall the actions taken globally to improve the viral safety of
coagulation factor concentrates, mainly in the years 1985–1990, at a time of confusing and …

Introduction: Glanzmann's thrombasthenia (GT) is a rare inherited platelet disorder with
deficient/dysfunctional fibrinogen receptor αIIbβ3 important for platelet aggregation …

Aim The presence of occult hepatitis C virus (HCV) infection (OCI) is still controversial,
however, this infection cannot be ignored. Therefore, the current study aimed at assessing …

Previously untreated patients with severe hemophilia A are a vulnerable population at risk
for severe bleeding which is currently managed with exogenous clotting factor replacement …

11. Estey EH. Treatment of relapsed and refractory acute myelogenous leukemia. Leukemia.
2000; 14 (3): 476-479. 12. DiNardo CD, Rausch CR, Bent on C, et al. Clinical experience …

Transfusion-transmitted malaria remains a critical problem for blood banks due to a
symptomatic of Plasmodium infection. Malaria screening is not listed in the blood-borne …

Background: The rapid diagnostic tests play a pivotal role in the screening of viral markers in
blood qualification for transfusion in limited resource setting. Therefore, it is important to …

According to a recent publication, 36,000 units of red blood cells are transfused into patients
each day in the United States. 1 Fortunately, with excellent screening techniques now in …

Occult HCV infection (OCI) is described as the presence of HCV RNA in the liver and
peripheral blood mononuclear cells (PBMCs), with no HCV RNA in the serum. Single …